XML 36 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Loss per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Loss Per Share of Common Stock

The following table sets forth the computation of basic and diluted net loss per share of common stock for the periods indicated, in thousands except share and per share data:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Basic and diluted net loss per common share calculation:

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(4,423

)

 

$

(2,874

)

 

$

(16,673

)

 

$

(9,075

)

Change in fair value of derivative instruments

 

 

 

 

 

 

 

 

 

 

(5,047

)

Net loss attributable to common stockholders – basic

 

(4,423

)

 

 

(2,874

)

 

 

(16,673

)

 

 

(14,122

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding – basic

 

107,428,969

 

 

 

7,855,763

 

 

 

57,845,406

 

 

 

6,232,123

 

Net loss per share of common stock – basic

$

(0.04

)

 

$

(0.37

)

 

$

(0.29

)

 

$

(1.46

)

Weighted average common stock outstanding - diluted

 

107,428,969

 

 

 

7,855,763

 

 

 

57,845,406

 

 

 

8,452,338

 

Net loss per share of common stock - diluted

$

(0.04

)

 

$

(0.37

)

 

$

(0.29

)

 

$

(1.67

)

Schedule of Antidilutive Securities Excluded from Diluted Loss per Share

The following table provides a summary of instruments where underlying shares issuable upon exercise or conversion were excluded from the diluted loss per share calculation for the periods presented because their effect would be anti-dilutive. Additionally, the shares underlying the February 2025 Warrants, Funding Notes and Exchange Notes, each outstanding during the nine months ended September 30, 2025, were excluded from diluted loss per share as their effect would be anti-dilutive.

 

 

As of September 30,

 

 

2025

 

 

2024

 

Outstanding stock options

 

 

11,272,863

 

 

 

598,540

 

Outstanding restricted stock units

 

 

2,823,857

 

 

 

-

 

Preferred stock

 

 

28,190

 

 

 

28,190

 

Outstanding warrants (Note 13)

 

 

3,141,993

 

 

 

706,674

 

Total

 

 

17,266,903

 

 

 

1,333,404